相似文献
1
Comment on administration and scoring of the Neuropsychiatric Inventory in clinical trials.关于临床试验中神经精神科问卷的管理与评分的评论
Alzheimers Dement. 2008 Nov;4(6):390-4. doi: 10.1016/j.jalz.2008.09.002.
2
The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity in dementia.《神经精神疾病问卷-临床医生评定量表（NPI-C）的巴西版本：在痴呆症中的信度和效度》
Int Psychogeriatr. 2013 Sep;25(9):1503-11. doi: 10.1017/S1041610213000811. Epub 2013 Jun 14.
3
Caregiver-Administered Neuropsychiatric Inventory (CGA-NPI).照顾者实施的神经精神科问卷（CGA-NPI）
J Geriatr Psychiatry Neurol. 2004 Mar;17(1):32-5. doi: 10.1177/089198873258818.
4
Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).冰岛版伴有照料者困扰的神经精神科问卷（NPI-D）的验证
Nord J Psychiatry. 2012 Feb;66(1):26-32. doi: 10.3109/08039488.2011.593100. Epub 2011 Jul 20.
5
Patient and Caregiver Benefit From a Comprehensive Dementia Care Program: 1-Year Results From the UCLA Alzheimer's and Dementia Care Program.患者和护理人员受益于综合性痴呆症护理计划：来自加州大学洛杉矶分校阿尔茨海默病和痴呆症护理计划的 1 年结果。
J Am Geriatr Soc. 2019 Nov;67(11):2267-2273. doi: 10.1111/jgs.16085. Epub 2019 Jul 29.
6
Neuropsychiatric symptoms in Parkinson's disease: association with caregiver distress and disease severity.帕金森病的神经精神症状：与照料者痛苦和疾病严重程度的关系。
Int Psychogeriatr. 2020 Jun;32(6):733-739. doi: 10.1017/S1041610219001510. Epub 2019 Oct 24.
7
8
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia.神经精神问卷-临床医生评定量表（NPI-C）：修订版痴呆患者神经精神症状评估的信度和效度。
Int Psychogeriatr. 2010 Sep;22(6):984-94. doi: 10.1017/S1041610210000876. Epub 2010 Jul 1.
9
Values of the Minimal Clinically Important Difference for the Neuropsychiatric Inventory Questionnaire in Individuals with Dementia.痴呆患者神经精神问卷的最小临床重要差值的价值。
J Am Geriatr Soc. 2015 Jul;63(7):1448-52. doi: 10.1111/jgs.13473. Epub 2015 Jun 5.
10
Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire.神经精神症状的实际评估：神经精神症状问卷的更新可靠性、有效性及临界值
Am J Geriatr Psychiatry. 2025 May;33(5):524-534. doi: 10.1016/j.jagp.2024.10.014. Epub 2024 Oct 28.
引用本文的文献
1
Advances in the study of apathy related to cerebral small vessel disease.与脑小血管病相关的淡漠研究进展
Front Neurol. 2025 Feb 12;16:1513574. doi: 10.3389/fneur.2025.1513574. eCollection 2025.
2
iCare4Me for FTD: A pilot randomized study to improve self-care in caregivers of persons with frontotemporal degeneration.用于额颞叶痴呆的iCare4Me：一项改善额颞叶痴呆患者照料者自我护理的试点随机研究。
Alzheimers Dement (N Y). 2023 May 1;9(2):e12381. doi: 10.1002/trc2.12381. eCollection 2023 Apr-Jun.
3
Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.痴呆症治疗靶点的精神病学：干预措施设计的路线图。
J Alzheimers Dis. 2022;88(4):1203-1228. doi: 10.3233/JAD-215483.
4
Predicting neuropsychiatric symptoms of persons with dementia in a day care center using a facial expression recognition system.使用面部表情识别系统预测日托中心痴呆患者的神经精神症状。
Aging (Albany NY). 2022 Feb 3;14(3):1280-1291. doi: 10.18632/aging.203869.
5
Pilot Study of the Effects of Bright Ambient Therapy on Dementia Symptoms and Cognitive Function.明亮环境疗法对痴呆症状和认知功能影响的初步研究
Front Psychol. 2021 Dec 24;12:782160. doi: 10.3389/fpsyg.2021.782160. eCollection 2021.
6
Pharmacological treatment trials of agitation in Alzheimer's disease: A systematic review of ClinicalTrials.gov registered trials.阿尔茨海默病激越症状的药物治疗试验：对ClinicalTrials.gov注册试验的系统评价
Alzheimers Dement (N Y). 2021 Mar 30;7(1):e12157. doi: 10.1002/trc2.12157. eCollection 2021.
7
The efficacy of exergaming in people with major neurocognitive disorder residing in long-term care facilities: a pilot randomized controlled trial.长期护理机构中患有重大神经认知障碍的人群中，运动游戏的疗效：一项初步随机对照试验。
Alzheimers Res Ther. 2021 Mar 30;13(1):70. doi: 10.1186/s13195-021-00806-7.
8
Psychometric Properties of the Neuropsychiatric Inventory: A Review.神经精神问卷的心理测量特性：综述。
J Alzheimers Dis. 2022;86(4):1485-1499. doi: 10.3233/JAD-200739.
9
Gender role in sleep disturbances among older adults with traumatic brain injury.老年创伤性脑损伤患者睡眠障碍中的性别角色。
Int Rev Psychiatry. 2020 Feb;32(1):39-45. doi: 10.1080/09540261.2019.1657384. Epub 2019 Sep 23.
10
The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia.神经精神科问卷-日记评定量表（NPI-日记）：一种提高痴呆症神经精神症状评估稳定性的方法。
Dement Geriatr Cogn Dis Extra. 2018 Sep 10;8(3):306-320. doi: 10.1159/000490380. eCollection 2018 Sep-Dec.
本文引用的文献
1
Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study.卡巴拉汀对阿尔茨海默病相关严重激越状态下活动记录仪监测的运动活动的影响：一项安慰剂对照的前瞻性研究
Arch Gerontol Geriatr. 2007 Jul-Aug;45(1):19-26. doi: 10.1016/j.archger.2006.07.006. Epub 2006 Sep 11.
2
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.一项为期5个月的加兰他敏治疗阿尔茨海默病的随机、安慰剂对照试验。加兰他敏美国-10研究组。
Neurology. 2000 Jun 27;54(12):2269-76. doi: 10.1212/wnl.54.12.2269.
3
[Risperidone in the treatment of psychotic, affective and behavioral symptoms associated to Alzheimer's disease].利培酮治疗与阿尔茨海默病相关的精神病性、情感性及行为症状
Actas Esp Psiquiatr. 1999 May-Jun;27(3):185-90.
4
Beyond the cholinergic hypothesis: the effect of metrifonate and other cholinesterase inhibitors on neuropsychiatric symptoms in Alzheimer's disease.超越胆碱能假说：敌百虫及其他胆碱酯酶抑制剂对阿尔茨海默病神经精神症状的影响
Dement Geriatr Cogn Disord. 1998;9 Suppl 2:8-14. doi: 10.1159/000051193.
5
Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: the Neuropsychiatric Inventory Caregiver Distress Scale.评估神经精神症状对阿尔茨海默病的影响：神经精神症状问卷照顾者痛苦量表
J Am Geriatr Soc. 1998 Feb;46(2):210-5. doi: 10.1111/j.1532-5415.1998.tb02542.x.
6
The Neuropsychiatric Inventory: assessing psychopathology in dementia patients.神经精神科问卷：评估痴呆患者的精神病理学
Neurology. 1997 May;48(5 Suppl 6):S10-6. doi: 10.1212/wnl.48.5_suppl_6.10s.
7
The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.神经精神科问卷：痴呆患者精神病理学的综合评估
Neurology. 1994 Dec;44(12):2308-14. doi: 10.1212/wnl.44.12.2308.
Zotero 插件